Whole-Body Positron Emission Tomography/Computed Tomography Imaging and Staging of Orbital Lymphoma

Ophthalmology

Volumn 113, Issue 10, 2006, Pages 1854-1858

  Roe, Richard H ^a,b   Finger, Paul T ^a,b,c,d   Kurli, Madhavi ^a,d   Tena, Lawrence B ^a,c,d   Iacob, Codrin E ^d  

^a NEW YORK EYE CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^d NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANATOMY; ARTICLE; B CELL LYMPHOMA; BIOPSY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORBIT CANCER; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOTHERAPY; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASM STAGING; ORBITAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 33748959715     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.04.029     Document Type: Article

References (15)

1. Freeman C., Berg J.W., and Cutler S.J. Occurrence and prognosis of extranodal lymphomas. Cancer 29 (1972) 252-260
2. Metser U., Goor O., Lerman H., et al. PET-CT of extranodal lymphoma. AJR Am J Roentgenol 182 (2004) 1579-1586
3. Cahill M., Barnes C., Moriarty P., et al. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol 83 (1999) 742-747
4. Macapinlac H.A. FDG PET and PET/CT imaging in lymphoma and melanoma. Cancer J 10 (2004) 262-270
5. Schaefer N.G., Hany T.F., Taverna C., et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT?. Radiology 232 (2004) 823-829
6. Macapinlac H.A. The utility of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and combined positron emission tomography and computed tomography in lymphoma and melanoma. Mol Imaging Biol 6 (2004) 200-207
7. Allen-Auerbach M., Quon A., Weber W.A., et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 6 (2004) 411-416
8. Freudenberg L.S., Antoch G., Schutt P., et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 31 (2004) 325-329
9. Naumann R., Vaic A., Beuthien-Baumann B., et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 115 (2001) 793-800
10. Finger P.T., Kurli M., Wesley P., et al. Whole body PET/CT imaging for detection of metastatic choroidal melanoma. Br J Ophthalmol 88 (2004) 1095-1097
11. Kurli M., Reddy S., Tena L.B., et al. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol 140 (2005) 193-199
12. Reddy S., Kurli M., Tena L.B., and Finger P.T. PET/CT imaging: detection of choroidal melanoma. Br J Ophthalmol 89 (2005) 1265-1269
13. Von Schulthess G.K. Positron emission tomography versus positron emission tomography/computed tomography: from "unclear" to "new-clear" medicine. Mol Imaging Biol 6 (2004) 183-187
14. Seemann M.D. PET/CT: fundamental principles. Eur J Med Res 28 (2004) 241-246
15. Chan-Kai B.T., and Yen M.T. Combined positron emission tomography/computed tomography imaging of orbital lymphoma. Am J Ophthalmol 140 (2005) 531-533